Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth

Autor:	Xiaowei Zheng, Jiayan Lang, Yiye Li, Xiuchao Wang, He Ren, Xuexiang Han, Xiao Zhao, Keman Cheng, Jian Shi, Gregory J. Anderson, Guangjun Nie, Marzieh Geranpayehvaghei, Ruifang Zhao, Ying Zhao, Hao Qin, Jihui Hao, Yao Li
Rok vydání:	2020
Předmět:	Deferoxamine Iron Chelator Co delivery Pancreatic tumor business.industry General Engineering medicine Cancer research General Physics and Astronomy General Materials Science medicine.disease business medicine.drug
Zdroj:	ACS Nano. 14:1211-1211
ISSN:	1936-086X 1936-0851
DOI:	10.1021/acsnano.0c00042
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::77784ea3cb61e57473f0da45a39aeb5f https://doi.org/10.1021/acsnano.0c00042 Zobrazit plný text záznamu